Aug 08, 2024 / 08:30PM GMT
Operator
Greetings and welcome to the Vaxart business update and second-quarter 2024 financial results conference call. A question-and-answer session will follow management's opening remarks. Individual investors may submit written questions to IR at vaxart.com.
As a reminder, this conference is being recorded. I would now like to turn the webcast over to your host, Ed Berg, Senior Vice President and General Counsel.
Edward Berg - Vaxart Inc - Senior Vice President, General Counsel
Good afternoon and welcome to today's call. Joining us from Vaxart are Steven Lo, Chief Executive Officer, Dr Sean Tucker, Founder and Chief Scientific Officer. Dr James Cummings, Chief Medical Officer, and Phil Lee, Chief Financial Officer.
Before we begin, I would like to remind everyone that during this conference call, Vaxart may make forward looking statements, including statements about the company's financial results, financial guidance, its future business strategies and operations, its product development and regulatory progress, including statements about its
Q2 2024 Vaxart Inc Earnings Call Transcript
Aug 09, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers